M 274 (Tamoxifen 20 mg)

Pill imprint M 274 has been identified as Tamoxifen citrate 20 mg.

Tamoxifen is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer, male; breast cancer; breast cancer, palliative (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tamoxifen citrate

Imprint:

M 274

Strength:

20 mg

Color:

White

Size:

10.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Hormones/antineoplastics
Selective estrogen receptor modulators

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-0274

Inactive Ingredients:

lactose anhydrous
silicon dioxide
crospovidone
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.